Experimental Drug Doubles Survival Time For Pancreatic Cancer
Pancreatic cancer is the third leading cause of cancer-related deaths in the United States and is on track to become the second.
Advertisement
The recent study shows how researchers discovered a way to develop prostate cancer treatment more efficiently.
A novel process produces larger, faster-growing gut organoids for use in medical research and potential human tissue repair.
The new wearable tech could lead to quicker responses to cardiac arrest and higher survival rates.